Squarepoint’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-223,353
| Closed | -$36.9M | – | 3752 |
|
|
2021
Q2 | $36.9M | Buy |
223,353
+196,025
| +717% | +$32.7M | 0.14% | 141 |
|
|
2021
Q1 | $4.19M | Buy |
27,328
+2,705
| +11% | +$367K | 0.02% | 709 |
|
|
2020
Q4 | $3.09M | Sell |
24,623
-19,082
| -44% | -$2.13M | 0.02% | 704 |
|
|
2020
Q3 | $4.43M | Buy |
43,705
+10,404
| +31% | +$1.06M | 0.06% | 376 |
|
|
2020
Q2 | $3.24M | Buy |
33,301
+11,558
| +53% | +$1.08M | 0.05% | 474 |
|
|
2020
Q1 | $1.81M | Sell |
21,743
-41,270
| -65% | -$4.02M | 0.05% | 479 |
|
|
2019
Q4 | $7M | Buy |
63,013
+36,900
| +141% | +$3.8M | 0.04% | 395 |
|
|
2019
Q3 | $2.59M | Sell |
26,113
-37,806
| -59% | -$3.75M | 0.02% | 741 |
|
|
2019
Q2 | $6.34M | Sell |
63,919
-40,703
| -39% | -$3.88M | 0.06% | 364 |
|
|
2019
Q1 | $11.5M | Buy |
104,622
+57,932
| +124% | +$6.05M | 0.12% | 203 |
|
|
2018
Q4 | $4.29M | Buy |
46,690
+38,134
| +446% | +$3.86M | 0.05% | 448 |
|
|
2018
Q3 | $943K | Sell |
8,556
-120,188
| -93% | -$12.5M | 0.01% | 1021 |
|
|
2018
Q2 | $12M | Buy |
128,744
+123,144
| +2,199% | +$10.6M | 0.16% | 184 |
|
|
2018
Q1 | $465K | Sell |
5,600
-10,505
| -65% | -$933K | 0.01% | 1118 |
|
|
2017
Q4 | $1.47M | Buy |
16,105
+13,045
| +426% | +$1.09M | 0.03% | 663 |
|
|
2017
Q3 | $233K | Sell |
3,060
-5,629
| -65% | -$425K | ﹤0.01% | 1311 |
|
|
2017
Q2 | $652K | Sell |
8,689
-8,705
| -50% | -$603K | 0.01% | 859 |
|
|
2017
Q1 | $1.14M | Buy |
17,394
+10,413
| +149% | +$613K | 0.03% | 560 |
|
|
2016
Q4 | $385K | Sell |
6,981
-6,922
| -50% | -$380K | 0.02% | 983 |
|
|
2016
Q3 | $786K | Sell |
13,903
-5,645
| -29% | -$277K | 0.05% | 420 |
|
|
2016
Q2 | $816K | Buy |
19,548
+13,448
| +220% | +$620K | 0.05% | 417 |
|
|
2016
Q1 | $261K | Buy |
+6,100
| New | +$258K | 0.02% | 881 |
|
Other funds holding PRAH
Squarepoint's PRAH Position: Q3 2021 in Review
Squarepoint sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 223,353 shares — an estimated $36.9M sold.
Squarepoint first reported a position in PRAH in Q1 2016 and held it in 22 quarters. The position peaked at $36.9M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.
- Squarepoint reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
- Squarepoint sold 223,353 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $36.9M.
- Squarepoint first reported a position in PRA Health Sciences, Inc. in Q1 2016 and held it in 22 quarters.
- Squarepoint's PRA Health Sciences, Inc. position peaked at $36.9M in Q2 2021.
- 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.
Based on Squarepoint's 13F filing for Q3 2021, filed 15 Nov 2021.